Differential CXCR4 expression and function in subpopulations of the feline lymphoma cell line 3201 susceptible to feline immunodeficiency virus

Journal of Feline Medicine and Surgery

Volumn 12, Issue 4, 2010, Pages 269-277

  Tochikura, Tadafumi S ^a   Motokawa, Kenji ^b   Naito, Yuko ^a   Kozutsumi, Yasunori ^a   Tanabe Tochikura, Akiko ^c   Hohdatsu, Tsutomu ^d  

^a KYOTO UNIVERSITY   (Japan)

^b KITASATO INSTITUTE   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; CALCIUM; CHEMOKINE RECEPTOR CXCR4; STROMAL CELL DERIVED FACTOR 1; VIRUS DNA;

ANIMAL; ARTICLE; CAT; CELL LINE; ENVELOPE GENE; FELINE IMMUNODEFICIENCY VIRUS; GENETICS; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; PHYSIOLOGY; UPREGULATION; VIROLOGY;

ANIMALS; CALCIUM; CATS; CELL LINE, TRANSFORMED; CHEMOKINE CXCL12; CHEMOKINES, CXC; DNA, VIRAL; GENES, ENV; IMMUNODEFICIENCY VIRUS, FELINE; LYMPHOCYTES; RECEPTORS, CXCR4; UP-REGULATION;

FELIDAE; FELINE IMMUNODEFICIENCY VIRUS;

EID: 77950298864     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfms.2009.09.008     Document Type: Article

References (29)

1. Levy J.A. Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 57 (1993) 183-289
2. Pedersen N.C., Ho E., Brown M.L., and Yamamoto J.K. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235 (1987) 790-793
3. Letvin N.L., Daniel M.D., Sehgal P.K., et al. Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science 230 (1985) 71-73
4. Pedersen N.C., Yamamoto J.K., Ishida T., and Hansen H. Feline immunodeficiency virus infection. Vet Immunol Immunopathol 21 (1989) 111-129
5. Shimojima M., Miyazawa T., keda Y., et al. Use of CD134 as a primary receptor by the feline immunodeficiency virus. Science 303 (2004) 1192-1195
6. + T cells by using CD134 as a binding receptor. Proc Natl Acad Sci USA 101 (2004) 13044-13049
7. English R.V., Johnson C.M., Gebhard D.H., and Tompkins M.B. In vivo lymphocyte tropism of feline immunodeficiency virus. J Virol 67 (1993) 5175-5186
8. Egberink H., Borst M., Niphuis H., et al. Suppression of feline immunodeficiency virus infection in vivo by 9-(2-phosphonomethoxyethyl)adenine. Proc Natl Acad Sci USA 87 (1990) 3087-3091
9. Lafrado L.J., Podell M., Krakowka S., Hayes K.A., Hanlon M.A., and Mathes L.E. FIV: a model for retrovirus-induced pathogenesis. AIDS Rev 3 (1993) 115-148
10. Oishi S., Kodera Y., Nishikawa H., et al. Design and synthesis of membrane fusion inhibitors against the feline immunodeficiency virus. Bioorg Med Chem 17 (2009) 4916-4920
11. Tochikura T.S., Hayes K.A., Cheney C.M., et al. In vitro replication and cytopathogenicity of the feline immunodeficiency virus for feline T4 thymic lymphoma 3201 cells. Virology 179 (1990) 492-497
12. Hosie M.J., Broere N., Hesselgesser J., et al. Modulation of feline Immunodeficiency virus infection by stromal cell-derived factor. J Virol 72 (1998) 2097-2104
13. Endo Y., Goto Y., Nishimura Y., et al. Inhibitory effect of stromal cell derived factor-1 on the replication of divergent strains of feline immunodeficiency virus in a feline T-lymphoid cell line. Vet Immunol Immunopathol 74 (2000) 303-314
14. Baribaud F., Edwards T.G., Sharron M., et al. Antigenically distinct conformations of CXCR4. J Virol 75 (2001) 8957-8967
15. Snyder Jr. H.W., Hardy Jr. W.D., Zuckerman E.E., and Fleissner E. Characterisation of a tumor-specific antigen on the surface of feline lymphosarcoma cells. Nature 275 (1978) 656-658
16. Sloane A.J., Raso V., Dimitrov D.S., et al. Marked structural and functional heterogeneity in CXCR4: separation of HIV-1 and SDF-1alpha responses. Immunol Cell Biol 83 (2005) 129-143
17. Talbott R.L., Sparger E.E., Lovelace K.M., et al. Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc Natl Acad Sci USA 86 (1989) 5743-5747
18. Hohdatsu T., Hirabayashi H., Motokawa K., and Koyama H. Comparative study of the cell tropism of feline immunodeficiency virus isolates of subtypes A, B and D classified on the basis of the env gene V3-V5 sequence. J Gen Virol 77 (1996) 93-100
19. Hohdatsu T., Motokawa K., Usami M., Amioka M., Okada S., and Koyama H. Genetic subtyping and epidemiological study of feline immunodeficiency virus by nested polymerase chain reaction-restriction fragment length polymorphism analysis of the gag gene. J Virol Methods 70 (1998) 107-111
20. Kusuhara H., Hohdatsu T., Okumura M., et al. Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats. Vet Microbiol 108 (2005) 155-165
21. Besmer P., Smotkin D., Haseltine W., et al. Mechanism of induction of RNA tumor viruses by halogenated pyrimidines. Cold Spring Harbor Symp Quant Biol 39 (1975) 1103-1107
22. Brunner D., and Pedersen N.C. Infection of peritoneal macrophages in vitro and in vivo with feline immunodeficiency virus. J Virol 63 (1989) 5483-5488
23. Ichiyama K., Yokoyama-Kumakura S., Tanaka Y., et al. A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity. Proc Natl Acad Sci USA 100 (2003) 4185-4190
24. Willett B.J., Picard L., Hosie M.J., Turner J.D., Adema K., and Clapham P.R. Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. J Virol 71 (1997) 6407-6415
25. Endres M.J., Clapham P.R., Marsh M., et al. CD4-independent infection by HIV-2 is mediated by fusin. Cell 87 (1996) 745-756
26. Murphy P.M. The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol 12 (1994) 593-633
27. Huang Y., Paxton W.A., Wolinsky S.M., et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 2 (1996) 1240-1243
28. Bieniasz PD. Restriction factors: a defense against retroviral infection. Trends Microbiol 2003; 11: 286-91.
29. Saenz DT, Teo W, Olsen JC, Poeschla EM. Restriction of feline immunodeficiency virus by Ref1, Lv1, and primate TRIM5α proteins. J Virol 2005; 79: 15175-88.